Pulmonary sarcoidosis following stem cell transplantation: Is it more than a chance occurrence?BHAGAT, Rajesh; RIZZIERI, David A; VREDENBURGH, James J et al.Chest. 2004, Vol 126, Num 2, pp 642-644, issn 0012-3692, 3 p.Article

Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantationGOTTFREDSSON, Magnus; VREDENBURGH, James J; JIANPING XU et al.Cancer. 2003, Vol 98, Num 1, pp 24-30, issn 0008-543X, 7 p.Article

Fatal re-expansion pulmonary edema associated with increased lung IL-8 levels following high-dose chemotherapy and autologous stem cell transplantGARANTZIOTIS, Stavros; BHALLA, Karan S; LONG, Gwynn D et al.Respiration (Basel). 2002, Vol 69, Num 4, pp 351-354, issn 0025-7931Article

The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed GlioblastomaVREDENBURGH, James J; DESJARDINS, Annick; FRIEDMAN, Allan H et al.Clinical cancer research (Print). 2011, Vol 17, Num 12, pp 4119-4124, issn 1078-0432, 6 p.Article

Phase I Pharmacokinetic Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Vatalanib (PTK787) Plus Imatinib and Hydroxyurea for Malignant GliomaREARDON, David A; EGORIN, Merrill J; DESJARDINS, Annick et al.Cancer. 2009, Vol 115, Num 10, pp 2188-2198, issn 0008-543X, 11 p.Article

Molecularly targeted therapy for malignant gliomaSATHOMSUMETEE, Sith; REARDON, David A; DESJARDINS, Annick et al.Cancer. 2007, Vol 110, Num 1, pp 13-24, issn 0008-543X, 12 p.Article

Phase II Trial of Temozolomide Plus O⁶-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant GliomaQUINN, Jennifer A; JIANG, Sara Xiaoyin; MCLENDON, Roger E et al.Journal of clinical oncology. 2009, Vol 27, Num 8, pp 1262-1267, issn 0732-183X, 6 p.Article

Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant GliomasDESJARDINS, Annick; REARDON, David A; SIGNER, Darell D et al.Clinical cancer research (Print). 2008, Vol 14, Num 21, pp 7068-7073, issn 1078-0432, 6 p.Article

Bevacizumab Plus irinotecan in recurrent glioblastoma multiformeVREDENBURGH, James J; DESJARDINS, Annick; WAGNER, Melissa et al.Journal of clinical oncology. 2007, Vol 25, Num 30, pp 4722-4729, issn 0732-183X, 8 p.Article

Phase II feasibility and pharmacokinetic study of concurrent administration of trastuzumab and high-dose chemotherapy in advanced HER2+ breast cancerNIETO, Yago; VREDENBURGH, James J; JONES, Roy B et al.Clinical cancer research. 2004, Vol 10, Num 21, pp 7136-7143, issn 1078-0432, 8 p.Article

Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimenRIZZIERI, David A; LONG, Gwynn D; VREDENBURGH, James J et al.Blood. 2001, Vol 98, Num 12, pp 3486-3488, issn 0006-4971Article

ADDITION OF BEVACIZUMAB TO STANDARD RADIATION THERAPY AND DAILY TEMOZOLOMIDE IS ASSOCIATED WITH MINIMAL TOXICITY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORMEVREDENBURGH, James J; DESJARDINS, Annick; FRIEDMAN, Allan et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 1, pp 58-66, issn 0360-3016, 9 p.Article

Exercise Behavior, Functional Capacity, and Survival in Adults With Malignant Recurrent GliomaRUDEN, Emily; REARDON, David A; FRIEDMAN, Allan H et al.Journal of clinical oncology. 2011, Vol 29, Num 21, pp 2918-2923, issn 0732-183X, 6 p.Article

Overall Survival of Newly Diagnosed Glioblastoma Patients Receiving Carmustine Wafers Followed by Radiation and Concurrent Temozolomide Plus Rotational Multiagent ChemotherapyLOU AFFRONTI, Mary; HEERY, Christopher R; HERNDON, James E et al.Cancer. 2009, Vol 115, Num 15, pp 3501-3511, issn 0008-543X, 11 p.Article

Partially matched, nonmyeloablative allogeneic transplantation : Clinical outcomes and immune reconstitutionRIZZIERI, David A; LIANG PIU KOH; NIEDZWIECKI, Donna et al.Journal of clinical oncology. 2007, Vol 25, Num 6, pp 690-697, issn 0732-183X, 8 p.Article

Phase II trial of bevacizumab and irinotecan in recurrent malignant gliomaVREDENBURGH, James J; DESJARDINS, Annick; BIGNER, Darell D et al.Clinical cancer research. 2007, Vol 13, Num 4, pp 1253-1259, issn 1078-0432, 7 p.Article

Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantationSNYDER, Matthew J; STENZEL, Timothy T; BUCKLEY, Patrick J et al.The American journal of surgical pathology. 2004, Vol 28, Num 6, pp 794-800, issn 0147-5185, 7 p.Article

Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humansMITCHELL, Duane A; XIUYU CUI; HERNDON, James E et al.Blood. 2011, Vol 118, Num 11, pp 3003-3012, issn 0006-4971, 10 p.Article

Phase 2 Study of Carboplatin, Irinotecan, and Bevacizumab for Recurrent Glioblastoma After Progression on Bevacizumab TherapyREARDON, David A; DESJARDINS, Annick; FRIEDMAN, Allan H et al.Cancer. 2011, Vol 117, Num 23, pp 5351-5358, issn 0008-543X, 8 p.Article

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed GlioblastomaSAMPSON, John H; HEIMBERGER, Amy B; REARDON, David A et al.Journal of clinical oncology. 2010, Vol 28, Num 31, pp 4722-4729, issn 0732-183X, 8 p.Article

Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and IrinotecanSATHORNSUMETEE, Sith; YITING CAO; MARCELLO, Jennifer E et al.Journal of clinical oncology. 2008, Vol 26, Num 2, pp 271-278, issn 0732-183X, 8 p.Article

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiformeREARDON, David A; EGORIN, Merrill J; DOWELL, Jeannette M et al.Journal of clinical oncology. 2005, Vol 23, Num 36, pp 9359-9368, issn 0732-183X, 10 p.Article

Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphomaRIZZIERI, David A; SAND, Gregory J; FOSTER, Tracy et al.Cancer. 2004, Vol 100, Num 11, pp 2408-2414, issn 0008-543X, 7 p.Article

SAFETY AND EFFICACY OF STEREOTACTIC RADIOSURGERY AND ADJUVANT BEVACIZUMAB IN PATIENTS WITH RECURRENT MALIGNANT GLIOMASCUNEO, Kyle C; VREDENBURGH, James J; SAMPSON, John H et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 5, pp 2018-2024, issn 0360-3016, 7 p.Article

Phase 1 Trial of Temozolomide Plus Irinotecan Plus O⁶-Benzylguanine in Adults With Recurrent Malignant GliomaQUINN, Jennifer A; XIAOYIN JIANG, Sara; REARDON, David A et al.Cancer. 2009, Vol 115, Num 13, pp 2964-2970, issn 0008-543X, 7 p.Article